Results 11 to 20 of about 4,931,657 (150)

Mammary Paget's Disease: An Update. [PDF]

open access: yesCancers (Basel), 2022
SIMPLE SUMMARY: Mammary Paget’s disease of the breast is an uncommon and often misdiagnosed breast malignancy. The review discusses the diagnosis, work-up, treatment, and prognosis of mammary Paget’s disease.
Markarian S, Holmes DR.
europepmc   +3 more sources

HER2 Negative Mammary Paget’s Disease or In Situ Melanoma? A Case Report and Review of the Literature

open access: yesCase Reports in Pathology, 2023
Mammary Paget’s disease (MPD) is a rare histological condition, accounting for 1-4% of female breast cancers, which may appear either independently (1.4-13% of the cases), or in association with an in situ or invasive ductal carcinoma (approximately 90 ...
Luana-Andreea Boșoteanu   +3 more
doaj   +2 more sources

An Unusual Case of Mammary Paget’s Disease Diagnosed Using Dynamic Contrast-Enhanced MRI [PDF]

open access: yesCase Reports in Radiology, 2013
Mammary Paget’s disease is a rare presentation of breast cancer. At clinical examination, it is characterized by skin lesions of the nipple-areola complex, almost always a sign of malignancy.
Eleonora Gaspari   +5 more
doaj   +2 more sources

Keratin Expression in Mammary Paget’s Disease in situ with Intraductal Invasion

open access: yesCase Reports in Oncology, 2012
We performed immunohistochemical studies of epithelial keratins in intraductal carcinoma in situ (IDCIS) in mammary Paget’s disease (MPD). K7, K8 and K18 were expressed in IDCIS in MPD. However, K19 was not expressed in IDCIS in MPD.
Ichiro Kurokawa   +4 more
doaj   +2 more sources

A Case Report of Short‐Term Metastasis After Surgery for Mammary Paget's Disease

open access: yesClinical Case Reports
Mammary Paget's disease (MPD) with ductal carcinoma in situ (DCIS) pathology can metastasize rapidly. HER2‐positive status likely drives aggression, warranting early postoperative systemic imaging and close surveillance.
Chao Wang   +6 more
doaj   +2 more sources

Comparison of the biomarkers for targeted therapies in primary extra‐mammary and mammary Paget's disease

open access: yesCancer Medicine, 2020
Background Primary Extra‐mammary Paget's disease (EMPD) is a very rare cutaneous adenocarcinoma affecting anogenital or axillary regions. It is characterized by a prolonged course with recurrences and eventually distant metastatic spread for which no ...
Zoran Gatalica   +11 more
doaj   +2 more sources

Case Report: Hidden danger in breast eczematous lesions: cutaneous metastasis from silent lung adenocarcinoma misdiagnosed as Paget’s disease [PDF]

open access: yesFrontiers in Oncology
BackgroundCutaneous metastasis from lung adenocarcinoma is uncommon and may clinically mimic primary dermatologic or breast diseases, particularly when it involves the nipple-areola complex.
Zhenni Gong   +15 more
doaj   +2 more sources

Significant efficacy of trastuzumab emtansine in HER2-positive relapsed mammary Paget’s disease: a case report and literature review [PDF]

open access: yesDiscover Oncology
A 58-year-old female patient was referred to our hospital due to a left chest wall relapse after a surgical excision 20 years ago. She received taxanes and trastuzumab regimen treatment for chest wall recurrence in 2019, but subsequently discontinued the
Weiping Li   +7 more
doaj   +2 more sources

Traditional Chinese Medicine Combined With Chemotherapy for Mammary Paget's Disease With Multifocal Heterogeneous Breast Cancer: A Case Report

open access: yesClinical Case Reports
Mammary Paget's disease with ipsilateral multifocal, heterogeneous molecular subtype breast cancer is extremely rare and lacks diagnostic or therapeutic guidelines.
Hongyu Cheng, Jiayin Tang, Chang Yao
doaj   +2 more sources

Paget’s disease of the breast: a contemporary perspective

open access: yesИсследования и практика в медицине, 2023
The treatment strategy for Paget’s breast cancer (PBC), as for other morphological forms, is determined by the spread of the invasive tumor process, as well as the absence or presence of adverse factors. Significant prognostic factors, e.g.
O. O. Yemelyanova   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy